296 related articles for article (PubMed ID: 16839731)
1. [Antibiotics for acute exacerbations of chronic obstructive pulmonary disease (COPD)].
Burgel PR
Med Mal Infect; 2006; 36(11-12):706-17. PubMed ID: 16839731
[TBL] [Abstract][Full Text] [Related]
2. [The role of macrolides in treatment of exacerbations of chronic obstructive pulmonary disease].
Targowski T; Jahnz-Rózyk K
Pol Merkur Lekarski; 2010 Apr; 28(166):311-4. PubMed ID: 20491344
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial therapy of acute infectious exacerbation of chronic obstructive pulmonary disease.
Chelidze K; Jgarkava M
Georgian Med News; 2008 Jun; (159):27-30. PubMed ID: 18633147
[TBL] [Abstract][Full Text] [Related]
4. Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease.
Ruiz-González A; Giménez A; Gómez-Arbonés X; Soler-González J; Sánchez V; Falguera M; Porcel JM
Respirology; 2007 Jan; 12(1):117-21. PubMed ID: 17207036
[TBL] [Abstract][Full Text] [Related]
5. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.
Sethi S; Evans N; Grant BJ; Murphy TF
N Engl J Med; 2002 Aug; 347(7):465-71. PubMed ID: 12181400
[TBL] [Abstract][Full Text] [Related]
6. Severe exacerbations of COPD patients: the role of pulmonary infections.
Fagon JY; Chastre J
Semin Respir Infect; 1996 Jun; 11(2):109-18. PubMed ID: 8776780
[TBL] [Abstract][Full Text] [Related]
7. [Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: analysis of comparative trials].
Garré M; Garo B; Ansart S; Le Berre R
Med Mal Infect; 2006; 36(11-12):690-6. PubMed ID: 16824719
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD).
Butorac-Petanjek B; Parnham MJ; Popovic-Grle S
J Chemother; 2010 Oct; 22(5):291-7. PubMed ID: 21123150
[TBL] [Abstract][Full Text] [Related]
9. Prulifloxacin in the treatment of acute exacerbations of COPD in cigarette smokers.
Pasqua F; Biscione G; Crigna G; Cazzola M
Ther Adv Respir Dis; 2008 Aug; 2(4):209-14. PubMed ID: 19124373
[TBL] [Abstract][Full Text] [Related]
10. A prediction model for bacterial etiology in acute exacerbations of COPD.
Lode H; Allewelt M; Balk S; De Roux A; Mauch H; Niederman M; Schmidt-Ioanas M
Infection; 2007 Jun; 35(3):143-9. PubMed ID: 17565454
[TBL] [Abstract][Full Text] [Related]
11. Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease.
van der Valk P; Monninkhof E; van der Palen J; Zielhuis G; van Herwaarden C; Hendrix R
Clin Infect Dis; 2004 Oct; 39(7):980-6. PubMed ID: 15472849
[TBL] [Abstract][Full Text] [Related]
12. [Role of antibiotherapy in acute exacerbation of chronic obstructive pulmonary disease].
Cavassini M; Calandra T; Bridevaux PO
Rev Med Suisse; 2007 Apr; 3(106):939-42. PubMed ID: 17575969
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acute exacerbation of severe-to-very severe COPD with azithromycin in patients vaccinated against Streptococcus pneumoniae.
Cazzola M; Salzillo A; De Giglio C; Piccolo A; Califano C; Noschese P
Respir Med; 2005 Jun; 99(6):663-9. PubMed ID: 15878482
[TBL] [Abstract][Full Text] [Related]
14. [Bacterial pathogens in sputum and degree of bronchial obstruction in patients with acute exacerbation of chronic obstructive pulmonary disease].
Biagini M; Rossi M
Recenti Prog Med; 2002 Sep; 93(9):470-3. PubMed ID: 12355983
[TBL] [Abstract][Full Text] [Related]
15. [Decision guidance for antibiotic treatment of acute exacerbation of COPD].
Kolditz M; Höffken G
MMW Fortschr Med; 2007 Mar; 149(11):38-40; quiz 41. PubMed ID: 20104700
[TBL] [Abstract][Full Text] [Related]
16. Bacterial infection and risk factors in outpatients with acute exacerbation of chronic obstructive pulmonary disease: a 2-year prospective study.
Alamoudi OS
Respirology; 2007 Mar; 12(2):283-7. PubMed ID: 17298464
[TBL] [Abstract][Full Text] [Related]
17. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage].
Cazzola M; Noschese P; Vinciguerra A; Di Perna F; Califano C; Berra A
Minerva Med; 1998; 89(1-2):15-22. PubMed ID: 9561021
[TBL] [Abstract][Full Text] [Related]
19. Relation of sputum colour to bacterial load in acute exacerbations of COPD.
Brusse-Keizer MG; Grotenhuis AJ; Kerstjens HA; Telgen MC; van der Palen J; Hendrix MG; van der Valk PD
Respir Med; 2009 Apr; 103(4):601-6. PubMed ID: 19027281
[TBL] [Abstract][Full Text] [Related]
20. Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease.
Sethi S; Sethi R; Eschberger K; Lobbins P; Cai X; Grant BJ; Murphy TF
Am J Respir Crit Care Med; 2007 Aug; 176(4):356-61. PubMed ID: 17478618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
